Literature DB >> 17137618

Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene.

William W Au1, Salama Abdou-Salama, Ayman Al-Hendy.   

Abstract

OBJECTIVE: Estrogen stimulates human papilloma virus oncogene expression, promotes cervical cancer (CC) cell proliferation and prevents apoptosis. Therefore, blockage of estrogen function may have therapeutic application to CC.
METHODS: CasKi CC cells were transfected with an adenovirus expressing a dominant negative estrogen receptor gene (Ad-ER-DN) and their responses were investigated by RT-PCR, Flow Cytometry and Western blot assays. RESULT: Transfected cells showed disturbance of cell colony morphology, reduced HPV E6 and E7 mRNA, interruption of cell proliferation, reduced cyclin D1 protein and expression of apoptosis.
CONCLUSION: We report, for the first time, the use of Ad-ER-DN to block estrogen receptors which led to dramatic changes in CC cells that are consistent with the possible reactivation of cellular p53 and Rb function. Their reactivation most likely allowed the recognition of existing chromosome abnormalities as a serious stress signal and the initiation of a cascade of cellular events in response to the stress, including the activation of the core apoptotic machinery which led to self-destruction of the CC cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17137618      PMCID: PMC1831876          DOI: 10.1016/j.ygyno.2006.10.015

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  29 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  A transmembrane intracellular estrogen receptor mediates rapid cell signaling.

Authors:  Chetana M Revankar; Daniel F Cimino; Larry A Sklar; Jeffrey B Arterburn; Eric R Prossnitz
Journal:  Science       Date:  2005-02-10       Impact factor: 47.728

3.  Ovarian cancer gene therapy: repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model.

Authors:  A Al-Hendy; A M Magliocco; T Al-Tweigeri; G Braileanu; N Crellin; H Li; T Strong; D Curiel; P J Chedrese
Journal:  Am J Obstet Gynecol       Date:  2000-03       Impact factor: 8.661

4.  Gel-based application of siRNA to human epithelial cancer cells induces RNAi-dependent apoptosis.

Authors:  Ming Jiang; Carlos P Rubbi; Jo Milner
Journal:  Oligonucleotides       Date:  2004

5.  Dominant negative ER induces apoptosis in GH(4) pituitary lactotrope cells and inhibits tumor growth in nude mice.

Authors:  E J Lee; W R Duan; M Jakacka; B D Gehm; J L Jameson
Journal:  Endocrinology       Date:  2001-09       Impact factor: 4.736

6.  Sensitivity of the cervical transformation zone to estrogen-induced squamous carcinogenesis.

Authors:  D A Elson; R R Riley; A Lacey; G Thordarson; F J Talamantes; J M Arbeit
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

Review 7.  Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.

Authors:  Sagar Sengupta; Bohdan Wasylyk
Journal:  Ann N Y Acad Sci       Date:  2004-06       Impact factor: 5.691

8.  Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells.

Authors:  Ala-Eddin Al Moustafa; William D Foulkes; Annick Wong; Houda Jallal; Gerald Batist; Qunyan Yu; Meenhard Herlyn; Piotr Sicinski; Moulay A Alaoui-Jamali
Journal:  Oncogene       Date:  2004-07-01       Impact factor: 9.867

9.  Repression of endogenous estrogen receptor activity in MCF-7 human breast cancer cells by dominant negative estrogen receptors.

Authors:  B A Ince; D J Schodin; D J Shapiro; B S Katzenellenbogen
Journal:  Endocrinology       Date:  1995-08       Impact factor: 4.736

10.  Gene therapy of uterine leiomyomas: adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice.

Authors:  Ayman Al-Hendy; Eun J Lee; Hui Q Wang; John A Copland
Journal:  Am J Obstet Gynecol       Date:  2004-11       Impact factor: 8.661

View more
  8 in total

1.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

2.  Aspirin and Acetaminophen Use and the Risk of Cervical Cancer.

Authors:  Grace Friel; Cici S Liu; Nonna V Kolomeyevskaya; Shalaka S Hampras; Bridget Kruszka; Kristina Schmitt; Rikki A Cannioto; Shashikant B Lele; Kunle O Odunsi; Kirsten B Moysich
Journal:  J Low Genit Tract Dis       Date:  2015-07       Impact factor: 1.925

3.  Raloxifene suppress proliferation-promoting function of estrogen in CaSKi cervical cells.

Authors:  Jing-Quan Ma; Xing-Hua Wang; Li-Ping Tang; Xiu-Wei Chen; Ge Lou
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 4.  Gene Therapy for Malignant and Benign Gynaecological Disorders: A Systematic Review of an Emerging Success Story.

Authors:  Ekati Drakopoulou; Nicholas P Anagnou; Kalliopi I Pappa
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 5.  The p53-estrogen receptor loop in cancer.

Authors:  C Berger; Y Qian; X Chen
Journal:  Curr Mol Med       Date:  2013-09       Impact factor: 2.222

6.  Towards fibroid gene therapy: adenovirus-mediated delivery of herpes simplex virus 1 thymidine kinase gene/ganciclovir shrinks uterine leiomyoma in the Eker rat model.

Authors:  Memy Hassan; Dong Zhang; Salama Salama; Farid Hamada; Hossam Arafa; Hala Fouad; Cheryl Walker; Ayman Al-Hendy
Journal:  Gynecol Obstet Invest       Date:  2009-03-27       Impact factor: 2.031

7.  Abrogation of estrogen receptor signaling augments cytotoxicity of anticancer drugs on CaSki cervical cancer cells.

Authors:  Moon Y Heo; Salama A Salama; Nilufar Khatoon; Ayman Al-Hendy; William W Au
Journal:  Anticancer Res       Date:  2008 Jul-Aug       Impact factor: 2.480

Review 8.  Targeted Gene Delivery Therapies for Cervical Cancer.

Authors:  Ángela Áyen; Yaiza Jiménez Martínez; Houria Boulaiz
Journal:  Cancers (Basel)       Date:  2020-05-21       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.